What Will Vaxart Inc (NASDAQ: VXRT) Be Like In 2024

Vaxart Inc (NASDAQ:VXRT) shares, rose in value, with the stock price down by -0.81% to the previous day’s close as strong demand from buyers drove the stock to $1.23.

Actively observing the price movement in the last trading, the stock closed the session at $1.24. The value of beta (5-year monthly) was 0.44. Referring to stock’s 52-week performance, its high was $1.59, and the low was $0.53. On the whole, VXRT has fluctuated by 0.41% over the past month.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

With the market capitalization of Vaxart Inc currently standing at about $213.85 million, investors are eagerly awaiting this quarter’s results, scheduled for May 02, 2024 – May 06, 2024. As a result, investors might want to see an improvement in the stock’s price before the company announces its earnings report. Analysts are projecting the company’s earnings per share (EPS) to be -$0.14, which is expected to increase to -$0.12 for fiscal year -$0.45 and then to about -$0.39 by fiscal year 2025. Data indicates that the EPS growth is expected to be 21.10% in 2025, while the next year’s EPS growth is forecast to be 13.30%.

Wall Street analysts also predicted that in 2025, the company’s y-o-y revenues would reach $14.73 million, representing an increase of 99.60% from the revenues reported in the last year’s results.

Revisions could be a useful indicator to get insight on short-term price movement; so for the company, there were no upward and no downward review(s) in last seven days. We see that VXRT’s technical picture suggests that short-term indicators denote the stock is a 100% Buy on average. However, medium term indicators have put the stock in the category of 100% Buy while long term indicators on average have been pointing out that it is a 100% Buy.

The stock’s technical analysis shows that the PEG ratio is about 0, with the price of VXRT currently trading nearly 2.76% and 5.72% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 52.98, while the 7-day volatility ratio is showing 7.29% which for the 30-day chart, stands at 7.70%. Furthermore, Vaxart Inc (VXRT)’s beta value is 0.58, and its average true range (ATR) is 0.09.

A comparison of Vaxart Inc (VXRT) with its peers suggests the former has fared considerably weaker in the market. VXRT showed an intraday change of -0.81% in last session, and over the past year, it grew by 62.55%%.

Data on historical trading for Vaxart Inc (NASDAQ:VXRT) indicates that the trading volumes over the past 10 days have averaged 1.6 million and over the past 3 months, they’ve averaged 2.04 million. According to company’s latest data on outstanding shares, there are 173.86 million shares outstanding.

Nearly 1.36% of Vaxart Inc’s shares belong to company insiders and institutional investors own 18.03% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 15.61 million shares as on Mar 15, 2024, resulting in a short ratio of 8.7. According to the data, the short interest in Vaxart Inc (VXRT) stood at 8.98% of shares outstanding as of Mar 15, 2024; the number of short shares registered in Feb 15, 2024 reached 12.67 million. The stock has risen by 114.73% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the VXRT stock heading into the next quarter.